Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues - Wikidata - wikimedia - TriplyDB

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

http://www.wikidata.org/entity/Q33982537

about

Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma RTA promoter demethylation and histone acetylation regulation of murine gammaherpesvirus 68 reactivation Newly emerging therapies targeting viral-related lymphomas.Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo Viral response to chemotherapy in endemic burkitt lymphoma Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas.Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors Identification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus.Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.Virally targeted therapies for EBV-associated malignancies.Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication.Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents.Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation.Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma Imaging virus-associated cancer.An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus Conserved herpesvirus protein kinases.Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile The Epstein-Barr virus LF2 protein inhibits viral replication Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.Recent developments in the prevention and treatment of Epstein-Barr virus-associated lymphoproliferative diseases.Genipin as a novel chemical activator of EBV lytic cycle.Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle.Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization.The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGFbeta1 expression.Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas.Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma.SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function.Identification and characterization of the conserved nucleoside-binding sites in the Epstein-Barr virus thymidine kinase.

P2860

Q27016002-FBA895AC-963E-4FEA-94BC-29D1523FC681 Q33411313-E5E0AFBF-A2C8-41A3-B259-52C20AA1FA99 Q33699201-CEE09671-F11F-406E-BBF2-870221860A97 Q33755168-3B602352-3A98-44A5-A145-9346C6EA3B7E Q33767066-788ECC93-D2BE-47D9-B405-FB2801474316 Q34053519-2FD10339-7304-4F82-B052-B4EEF84B8C0F Q34120915-271A19BE-695C-49FE-BDEB-90F84698D966 Q34350013-913782B5-3F0F-4C38-AABE-F39C1A07F9AD Q34464958-13A17DE1-B9E7-4DE1-8E61-FC5D8415AA93 Q34767204-9D4609D6-61C3-4E13-A6C2-360A1D94A919 Q34985738-84D41A0D-26B8-4349-BED0-3A5FD0117ABB Q35107719-B0DFD0A8-F5C9-4EC4-9B1E-9116A70D87FD Q35196601-6C9EEE02-4061-4698-82C4-621CE3415E8E Q35660314-39E54673-ACA9-4EA7-913D-007DAC34279E Q35690817-ACF7E8F1-C9B0-4740-9787-FFC08C92CCC2 Q35733719-223E80BD-2484-4335-B891-C86116E07463 Q35795380-BA76CD87-89DE-40E4-A499-C8A28F071E01 Q35829978-8336D1C6-1F55-4F3F-8BFF-B945949BA896 Q35847814-B3283AB8-D257-4D93-83B6-228CA50021F5 Q36015054-56BC29F3-E9A2-43F7-B1EF-3C530E04FD97 Q36171933-6F4556AF-3A6A-4DD6-BC91-F8895C86AB7B Q36346985-3F9E5675-FF02-40E0-B273-C9DDF7393342 Q36491044-0E13805E-E968-4FA7-AE33-B7F8E0CB1E4C Q36687528-A4BD3A84-C8E7-4185-8AA6-83B3BB6AA00F Q36845933-B76FECE9-05DC-497B-A3D2-F660038997C8 Q37259751-8E5D5420-22F3-4CE6-A1AD-E54CF0C29CB7 Q37906623-3FF81755-996A-41D3-9CA4-65981B52AC64 Q38429112-80A0EDD7-61A9-4A92-B2C7-4AF770BA17B4 Q39537817-C2AC04CC-4504-4283-8A12-384E32CF37F2 Q39575256-E8011FEF-4F22-4DBC-BC7B-D67B79171875 Q39680157-81A261B2-2FCD-43E7-8647-2449038BFE2B Q39735571-D8FFDBAC-EAE3-4882-8101-E8A7BFEE299A Q39778922-D88ED8B0-937D-4B92-BD2D-5F6321B50E99 Q39798789-71B70D5D-532D-4176-8183-307D1D5B026F Q39962123-1470F7AD-B9C4-451D-9B56-3F264E19F6E8 Q40491223-AD23ABAD-3F5D-467B-84B6-F188E0A54211 Q40594969-72CA3499-D037-4090-9FE6-9E407BE59745 Q41165122-F8656EF7-7BA2-4FB9-868A-3F7B2791C3C4 Q41983297-D71808D4-7C9C-47EC-9045-5AA91288DB36 Q42002408-67365763-7945-4F69-8DE3-0FF80CFE387D

P2860

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

http://www.wikidata.org/entity/Q33982537

description

2001 nî lūn-bûn

@nan

2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

@ast

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

@en

type

label

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

@ast

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

@en

prefLabel

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

@ast

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

@en

P1433

Q33982537-7CB46ED4-D0AA-4EA2-87FC-38EA34F639DB

P1476

Q33982537-D2A79066-2F92-4010-84EE-199D5B4AB7F8

P2093

Q33982537-0FEC59CA-779C-4C10-B046-441EC1FAE362

Q33982537-2E4A10EE-435A-4F1C-B0BF-01F956750E4A

Q33982537-31504B0C-4B87-4375-B1C0-02C91E0232EA

Q33982537-38EF7295-C3F7-47E2-9212-B63E6F693C97

Q33982537-BC8AA0D9-9267-403D-A56E-30BB56858591

P2860

Q33982537-03FFDC87-ABDB-482E-8BA9-5DD4AAC45803

Q33982537-04E05BCE-BDF8-4BBE-8673-C955BF100852

Q33982537-093A76EC-B650-4956-8E58-99786899389D

Q33982537-0BD4AFFB-D7A3-466C-9F4F-127294945E2D

Q33982537-12DFA31D-000E-4BBE-B708-7BA95408797F

Q33982537-12ED468F-EBE4-4C79-B32C-3F2934FCD045

Q33982537-1A0C126C-9225-4811-B718-34FF1D762C9D

Q33982537-1DF66549-FE0F-4053-9C83-327FE30FDD7C

Q33982537-1ECF6E22-9052-4F65-A8D2-0ACD0E880B03

Q33982537-248CB59A-594C-499B-AF0F-4EF01A8B1C73

P304

Q33982537-B65561B0-8211-400E-9AE1-BB8B8CEB8F76

P31

Q33982537-69735F9B-F11C-4C6C-9898-191F9A4AACF8

P356

Q33982537-7629CD57-C9D3-4B93-A4C6-1C1D25C52CCA

P407

Q33982537-D71EF597-4625-443D-9EAC-F7B1FA8BD157

P433

Q33982537-6DD6E102-020B-446E-B704-1C4F083E86F1

P478

Q33982537-5DB0F660-E6FA-4676-B421-162CF869E4AA

P577

Q33982537-408170D3-879F-4501-AE7A-B7F28E383AA3

P5875

Q33982537-D07CDF40-F762-43DA-A1BC-7217246A808A

P698

Q33982537-426B8ED3-6495-42B1-8502-C1A6E6BF5A85

P921

Q33982537-71E728FE-7E77-4271-A48D-8480CBAECC74

P932

Q33982537-7F32580C-8B28-4CD3-9392-0641B8A8EA97

P356

AAC.45.7.2082-2091.2001

P1433

Antimicrobial Agents and Chemotherapy

P1476

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

@en

P2093

F M Hamzeh

http://www.w3.org/2001/XMLSchema#string

J S Cannon

http://www.w3.org/2001/XMLSchema#string

R F Ambinder

http://www.w3.org/2001/XMLSchema#string

S M Moore

http://www.w3.org/2001/XMLSchema#string

Y C Tanhehco

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of an Epstein-Barr virus-coded thymidine kinase.

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells

Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition

Production of high-titer helper-free retroviruses by transient transfection

A system for assaying homologous recombination at the endogenous human thymidine kinase gene.

Cloning and expression of a cDNA encoding the Epstein-Barr virus thymidine kinase gene.

Evaluation of continuous infusion low-dose 5-azacytidine in the treatment of myelodysplastic syndromes.

P304

2082-2091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.45.7.2082-2091.2001

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2001-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11932148

http://www.w3.org/2001/XMLSchema#string

P698

11408227

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

90604

http://www.w3.org/2001/XMLSchema#string